Scheduled Intellectual Property. On and as of the Closing Date, a Pledgor owns (a) all issued Patents and pending Patent applications issued by or filed at the USPTO listed on Section II.B.2 to the Perfection Certificate, (b) all registered Trademarks and Trademark applications registered by or filed at the USPTO listed in Section II.B.3 of the Perfection Certificate, (c) all registered Copyrights and Copyright applications pending at the USCO listed on Section II.B.1 to the Perfection Certificate and (d) all Licenses granting to a Pledgor any exclusive right with respect to any registered Copyright owned by a third party (“Exclusive Copyright Licenses”) listed on Section II.B.1 of the Perfection Certificate, except, in each case, where the failure to own or possess the right to use, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect. Except as set forth on Section II.B of the Perfection Certificate, as of the Closing Date, all such scheduled Intellectual Property Collateral (but excluding Exclusive Copyright Licenses) has not been abandoned and, to the knowledge of each Pledgor, is valid, subsisting and in full force and effect, except as could not reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: First Lien Credit Agreement (SolarWinds Corp), Security Agreement (SolarWinds Corp)
Scheduled Intellectual Property. On and as of the Closing Datedate hereof, a Pledgor owns (a) all issued Patents and pending Patent applications issued by or filed at the USPTO listed on in Section II.B.2 to 10(c) of the Perfection Certificate, (b) all registered Trademarks and Trademark applications registered by or filed at the USPTO listed in Section II.B.3 10(b) of the Perfection Certificate, (c) all registered Copyrights and Copyright applications pending at the USCO listed on in Section II.B.1 to 10(a) of the Perfection Certificate and (d) all Licenses granting to a Pledgor any exclusive right with respect to any registered Copyright owned by a third party (“Exclusive Copyright Licenses”) listed on in Section II.B.1 10(d) of the Perfection Certificate, except, in each case, where the failure to own or possess the right to use, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect. Except as set forth on in Section II.B 10 of the Perfection Certificate, as of the Closing Datedate hereof, all such scheduled Intellectual Property Collateral (but excluding Exclusive Copyright Licenses) has not been abandoned and, to the knowledge of each Pledgor, is valid, subsisting and in full force and effect, except as could not reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Security Agreement (Orexigen Therapeutics, Inc.), Security Agreement (Orexigen Therapeutics, Inc.)